Psychiatry Research: Neuroimaging
Volume 156, Issue 2 , Pages 169-174 , 15 November 2007

Reproducibility of magnetic resonance spectroscopy in correlation with signal-to-noise ratio

  • Tomohisa Okada

      Affiliations

    • Department of Molecular Imaging, Institute of Biomedical Research and Innovation, 2-2 Minatojima Minamimachi, Chuouku, Kobe, 650-0047, Japan
    • Department of Diagnostic Radiology, Kyoto University, 54 Shogoin Kawaharacho, Sakyoku, Kyoto, 606-8507, Japan
    • Corresponding Author InformationCorresponding author. Department of Diagnostic Radiology, Kyoto University, 54 Shogoin Kawaharacho, Sakyoku, Kyoto, 606-8507, Japan. Tel.: +81 75 751 4215; fax: +81 75 7514216.
    • ,
  • Setsu Sakamoto

      Affiliations

    • Department of Molecular Imaging, Institute of Biomedical Research and Innovation, 2-2 Minatojima Minamimachi, Chuouku, Kobe, 650-0047, Japan
    • ,
  • Yuji Nakamoto

      Affiliations

    • Department of Molecular Imaging, Institute of Biomedical Research and Innovation, 2-2 Minatojima Minamimachi, Chuouku, Kobe, 650-0047, Japan
    • Department of Diagnostic Radiology, Kyoto University, 54 Shogoin Kawaharacho, Sakyoku, Kyoto, 606-8507, Japan
    • ,
  • Nobuo Kohara

      Affiliations

    • Department of Neurology, Kobe City General Hospital, 4-6 Minatojima Nakamachi, Chuouku, Kobe, 650-0046, Japan
    • ,
  • Michio Senda

      Affiliations

    • Department of Molecular Imaging, Institute of Biomedical Research and Innovation, 2-2 Minatojima Minamimachi, Chuouku, Kobe, 650-0047, Japan

Received 13 April 2006 ,Revised 10 March 2007 ,Accepted 21 March 2007.

References 

  1. Bartha R, Drost DJ, Menon RS, Williamson PC. Comparison of the quantification precision of human short echo time (1)H spectroscopy at 1.5 and 4.0 Tesla. Magnetic Resonance in Medicine. 2000;44:185–192
  2. Brooks WM, Friedman SD, Stidley CA. Reproducibility of 1H-MRS in vivo. Magnetic Resonance in Medicine. 1999;41:193–197
  3. De Graaf R, Rothman D. In vivo detection and quantification of scalar coupled 1H NMR resonances. Concepts in Magnetic Resonance. 2001;13:32–76
  4. Felblinger J, Kreis R, Boesch C. Effects of physiologic motion of the human brain upon quantitative 1H-MRS: analysis and correction by retro-gating. NMR in Biomedicine. 1998;11:107–114
  5. Frahm J, Bruhn H, Gyngell ML, Merboldt KD, Hanicke W, Sauter R. Localized proton NMR spectroscopy in different regions of the human brain in vivo. Relaxation times and concentrations of cerebral metabolites. Magnetic Resonance in Medicine. 1989;11:47–63
  6. Helms G, Piringer A. Restoration of motion-related signal loss and line-shape deterioration of proton MR spectra using the residual water as intrinsic reference. Magnetic Resonance in Medicine. 2001;46:395–400
  7. Hoshino Y, Yoshikawa K, Inoue Y, Asai S, Nakamura T, Ogino T, et al. Reproducibility of short echo time proton magnetic resonance spectroscopy using point-resolved spatially localized spectroscopy sequence in normal human brains. Radiation Medicine. 1999;17:115–120
  8. Kantarci K, Jack CR, Xu YC, Campeau NG, O'Brien PC, Smith GE, et al. Regional metabolic patterns in mild cognitive impairment and Alzheimer's disease: a 1H MRS study. Neurology. 2000;55:210–217
  9. Krishnan KR, Charles HC, Doraiswamy PM, Mintzer J, Weisler R, Yu X, et al. Randomized, placebo-controlled trial of the effects of donepezil on neuronal markers and hippocampal volumes in Alzheimer's disease. American Journal of Psychiatry. 2003;160:2003–2011
  10. Lyketsos CG, Reichman WE, Kershaw P, Zhu Y. Long-term outcomes of galantamine treatment in patients with Alzheimer disease. American Journal of Geriatric Psychiatry. 2004;12:473–482
  11. Marshall I, Wardlaw J, Cannon J, Slattery J, Sellar RJ. Reproducibility of metabolite peak areas in 1H MRS of brain. Magnetic Resonance Imaging. 1996;14:281–292
  12. Miller BL, Moats RA, Shonk T, Ernst T, Woolley S, Ross BD. Alzheimer disease: depiction of increased cerebral myo-inositol with proton MR spectroscopy. Radiology. 1993;187:433–437
  13. Moats RA, Shonk T. Evaluation of automated MR spectroscopy: application in Alzheimer disease. American Journal of Neuroradiology. 1995;16:1779–1782
  14. Moats RA, Ernst T, Shonk TK, Ross BD. Abnormal cerebral metabolite concentrations in patients with probable Alzheimer disease. Magnetic Resonance in Medicine. 1994;32:110–115
  15. Moats RA, Watson L, Shonk T, Tokuyama S, Braslau D, Eto R, et al. Added value of automated clinical proton MR spectroscopy of the brain. Journal of Computer Assisted Tomography. 1995;19:480–491
  16. Mullins PG, Rowland L, Bustillo J, Bedrick EJ, Lauriello J, Brooks WM. Reproducibility of 1H-MRS measurements in schizophrenic patients. Magnetic Resonance in Medicine. 2003;50:704–707
  17. Parsey RV, Slifstein M, Hwang DR, Abi-Dargham A, Simpson N, Mawlawi O, et al. Validation and reproducibility of measurement of 5-HT1A receptor parameters with [carbonyl-11C]WAY-100635 in humans: comparison of arterial and reference tissue input functions. Journal of Cerebral Blood Flow and Metabolism. 2000;20:1111–1133
  18. Pattany PM, Khamis IH, Bowen BC, Goodkin K, Weaver RG, Murdoch JB, et al. Effects of physiologic human brain motion on proton spectroscopy: quantitative analysis and correction with cardiac gating. American Journal of Neuroradiology. 2002;23:225–230
  19. Rose SE, de Zubicaray GI, Wang D, Galloway GJ, Chalk JB, Eagle SC, et al. A 1H MRS study of probable Alzheimer's disease and normal aging: implications for longitudinal monitoring of dementia progression. Magnetic Resonance Imaging. 1999;17:291–299
  20. Shonk TK, Moats RA, Gifford P, Michaelis T, Mandigo JC, Izumi J, et al. Probable Alzheimer disease: diagnosis with proton MR spectroscopy. Radiology. 1995;195:65–72
  21. Stanley JA, Drost DJ, Williamson PC, Thompson RT. The use of a priori knowledge to quantify short echo in vivo 1H MR spectra. Magnetic Resonance in Medicine. 1995;34:17–24
  22. Star-Lack JM, Adalsteinsson E, Gold GE, Ikeda DM, Spielman DM. Motion correction and lipid suppression for 1H magnetic resonance spectroscopy. Magnetic Resonance in Medicine. 2000;43:325–330
  23. Thiel T, Czisch M, Elbel GK, Hennig J. Phase coherent averaging in magnetic resonance spectroscopy using interleaved navigator scans: compensation of motion artifacts and magnetic field instabilities. Magnetic Resonance in Medicine. 2002;47:1077–1082
  24. Webb PG, Sailasuta N, Kohler SJ, Raidy T, Moats RA, Hurd RE. Automated single-voxel proton MRS: technical development and multisite verification. Magnetic Resonance in Medicine. 1994;31:365–373
  25. Zhu G, Gheorghiu D, Allen PS. Motional degradation of metabolite signal strengths when using STEAM: a correction method. NMR in Biomedicine. 1992;5:209–211

PII: S0925-4927(07)00065-0

doi: 10.1016/j.pscychresns.2007.03.007

Psychiatry Research: Neuroimaging
Volume 156, Issue 2 , Pages 169-174 , 15 November 2007

Article Tools

* Image Usage & Resolution